Retrospective cohort study explores hormonal therapy's impact on cancer risks in women, suggesting new approaches for treatment.
These findings suggest considering lower-potency progestogens in current estrogen/progestogen. This change might increase endometrial cancer risk but reduce breast cancer risk, potentially lowering overall cancer risk.
No takes yet. Share an insight, caveat, or question.
Yuk et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: